FOR46
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for FOR46, covering 2025-08-27 to 2025-08-27. Get the full timeline:
Most recent: Clinical Trial Update: FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate Cancer [Phase 1, Phase 2]